Cancer Genomics - Proteomics: 2 (4)

July 01, 2005; Volume 2,Issue 4

You have access
Proteomic Analysis of Membrane-associated Proteins from the Breast Cancer Cell Line MCF7
C. PIONNEAU, L. CANELLE, J. BOUSQUET, J. HARDOUIN, J. BIGEARD, M. CARON and R. JOUBERT-CARON

Cancer Genomics & Proteomics July 2005, 2 (4) 199-207;
You have access
Specific Expression of Potential Tumour Marker Proteins, Similar to No On or Off Transient A and HIRA-interacting Protein 5, in Mouse N1E-115 Neuroblastoma Cell Line
JI-EUN OH, EPHREM ENGIDAWORK, JOO-HO SHIN and GERT LUBEC

Cancer Genomics & Proteomics July 2005, 2 (4) 209-218;
You have access
Biomarkers for Sensitivity to Docetaxel and Paclitaxel in Human Tumor Cell Lines In Vitro
ELZBIETA IZBICKA, DAVID CAMPOS, GILBERT CARRIZALES and ANTHONY TOLCHER

Cancer Genomics & Proteomics July 2005, 2 (4) 219-226;
You have access
Stathmin in Cell Proliferation and Cancer Progression
G.V. SHERBET and F. CAJONE

Cancer Genomics & Proteomics July 2005, 2 (4) 227-237;
You have access
The Cell Cycle Regulators P16^INK4a, P15^INK4b and Cyclin D1: Relationship to Clinicopathological Parameters and Disease-free Survival in Laryngeal Carcinoma Patients
EMAN EL-SALAHY, AZZA H. ABOU-GHALIA, AHMED ADLI and SAMAR K. KASSIM

Cancer Genomics & Proteomics July 2005, 2 (4) 239-245;
You have access
Tumor Suppressor Genes on Human Chromosome 3 and Cancer Pathogenesis
SIGURDUR INGVARSSON

Cancer Genomics & Proteomics July 2005, 2 (4) 247-253;

Main menu